Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cardiomyopathy Due to Anthracyclines”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Early research (Phase 1)Study completedNCT02509156
What this trial is testing

Stem Cell Injection in Cancer Survivors

Who this might be right for
Cardiomyopathy Due to Anthracyclines
The University of Texas Health Science Center, Houston 46
Testing effectiveness (Phase 2)WithdrawnNCT04190433
What this trial is testing

Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial

Who this might be right for
Breast CarcinomaHematopoietic and Lymphoid Cell NeoplasmLymphoma+1 more
Mayo Clinic
Post-approval studies (Phase 4)WithdrawnNCT03392740
What this trial is testing

Prophylactic Lisinopril to Prevent Anthracycline Cardiomyopathy.

Who this might be right for
Cardiomyopathy Due to DrugHeart Failure, Systolic
Ascension Health
Testing effectiveness (Phase 2)Study completedNCT04737265
What this trial is testing

Pilot Study of an NTproBNP Guided Strategy of Cardioprotection

Who this might be right for
CardiotoxicityToxicity Due to ChemotherapyBreast Cancer+3 more
Abramson Cancer Center at Penn Medicine 101
Not applicableLooking for participantsNCT06331806
What this trial is testing

Myocardial Fibrosis Identification in Patients With Anthracycline-induced Cardiotoxicity

Who this might be right for
Cardiomyopathy Due to Drug
European Institute of Oncology 100